BRTX vs SO · rev $401.0K vs P/E 22, rev $29.55B
BioRestorative Therapies Inc (BRTX) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
BRTX currently screens at market cap $10.2M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the BRTX and SO stock pages for the full models.
Not investment advice.